UK - AstraZeneca has dropped plans to sue Merrill Lynch Investment Managers over poor investment performance for its pension fund.
A spokesman for the pharmaceutical giant said the decision was made following advice from both its internal and external counsel. No other details were disclosed. However, MLIM, which made an ou...
To continue reading this article...
Join Professional Pensions
Become a Professional Pensions Lite Member today
- Three complimentary articles per month covering the latest real-time news, analysis and opinion from the industry
- Receive important and breaking news stories via our two daily news alerts
- Hear from industry experts and other forward-thinking leaders